|
[1]SONG TX, QI XS, GAO F, et al.Advances in diagnosis and treatment of hepatorenal syndrome type of acute kidney injury in patients with liver cirrhosis[J].J Clin Hepatol, 2017, 33 (3) :572-576. (in Chinese) 宋廷雪, 祁兴顺, 高帆, 等.肝硬化肝肾综合征型急性肾损伤的诊治进展[J].临床肝胆病杂志, 2017, 33 (3) :572-576.
|
|
[2]BELCHER JM, COCA SG, PARIKH CR.Creatinine change on vasoconstrictors as mortality surrogate in hepatorenal syndrome:Systematic review&Meta-analysis[J].PLo S One, 2015, 10 (8) :e0135625.
|
|
[3]GLASS L, SHARMA P.Evidence-based therapeutic options for hepatorenal syndrome[J].Gastroenterology, 2016, 150 (4) :1031-1033.
|
|
[4]WONG F, LEUNG W, AL BM, et al.Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation[J].Liver Transpl, 2015, 21 (3) :300-307.
|
|
[5]YAP DY, SETO WK, FUNG J, et al.Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis[J].Dig Liver Dis, 2017, 49 (2) :202-206.
|
|
[6]RLY B, CAREY WD, KAPOOR B, et al.Hepatorenal syndrome:A review of pathophysiology and current treatment options[J].Semin Intervent Radiol, 2015, 32 (4) :445-454.
|
|
[7]ENESCU A, PETRESCU F, MITRUT P, et al.Hepatorenal syndrome:Diagnosis and treatment-newsreel[J].Rom J Intern Med, 2016, 54 (3) :143-150.
|
|
[8]TAPPER EB, BONDER A, CARDENAS A.Preventing and treating acute kidney injury among hospitalized patients with cirrhosis and ascites:A narrative review[J].Am J Med, 2016, 129 (5) :461-467.
|
|
[9]XIONG HF, LIU JY.Research progress on hepatorenal syndrome[J/CD].Chin J Liver Dis:Electronic Edition, 2017, 9 (1) :1-6. (in Chinese) 熊号峰, 刘景院.肝肾综合征研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (1) :1-6.
|
|
[10]WANG JB.Pathophysiological basis of portal hypertension and the new concept of acute kidney injury in patients with liver cirrhosis[J].Chin J Hepatol, 2017, 25 (6) :408-410. (in Chinese) 王江滨.门静脉高压的发生基础及肝硬化急性肾损伤的新概念[J].中华肝脏病杂志, 2017, 25 (6) :408-410.
|
|
[11]GIFFORD FJ, MORLING JR, FALLOWFIELD JA.Systematic review with meta-analysis:Vasoactive drugs for the treatment of hepatorenal syndrome type 1[J].Aliment Pharmacol Ther, 2017, 45 (5) :593-603.
|
|
[12]SANYAL AJ, BOYER TD, FREDERICK RT, et al.Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs.placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies[J].Aliment Pharmacol Ther, 2017, 45 (11) :1390-1402.
|
|
[13]ZHANG Y, HU GQ, LIU P, et al.Research progress on the treatment of hepatorenal syndrome[J/CD].Chin J Liver Dis:Electronic Edition, 2017, 9 (3) :26-29. (in Chinese) 张彦, 胡国启, 刘萍, 等.肝肾综合征治疗的研究进展[J/CD].中国肝脏病杂志:电子版, 2017, 9 (3) :26-29.
|
|
[14]CAI CX, MADDUKURI G, JAIPAUL N, et al.A treat-to-target concept to guide the medical management of hepatorenal syndrome[J].Dig Dis Sci, 2015, 60 (5) :1474-1481.
|
|
[15]OKAMURA Y, HATA K, INAMOTO O, et al.Influence of hepatorenal syndrome on outcome of living donor liver transplantation:A single-center experience in 357 patients[J].Hepatol Res, 2017, 47 (5) :425-434.
|
|
[16]ACEVEDO JG, CRAMP ME.Hepatorenal syndrome:Update on diagnosis and therapy[J].World J Hepatol, 2017, 9 (6) :293-299.
|
|
[17]ZHANG LL, LI L, JI GX, et al.The value of serum Cys C in diagnosis of subclinical hepatorenal syndrome[J].Chin J Gastroenterol Hepatol, 2017, 26 (1) :25-28. (in Chinese) 张利利, 李莉, 纪桂贤, 等.血清Cys C在亚临床肝肾综合征中的诊断价值[J].胃肠病学和肝病学杂志, 2017, 26 (1) :25-28.
|
|
[18]WANG D, FENG JF, WANG AQ, et al.Role of Cystatin C and glomerular filtration rate in diagnosis of kidney impairment in hepatic cirrhosis patients[J].Medicine, 2017, 96 (20) :e6949.
|
|
[19]UGUEN T, JEZEQUEL C, ROPERT M, et al.Pretransplant renal function according to CKD-EPI cystatin C equation is a prognostic factor of death after liver transplantation[J].Liver Int, 2016, 36 (4) :547-554.
|
|
[20]STAYNER C, POOLE CA, MCGLASHAN SR, et al.An ovine hepatorenal fibrocystic model of a Meckel-like syndrome associated with dysmorphic primary cilia and TMEM67 mutations[J].Sci Rep, 2017, 7 (1) :1601.
|
|
[21]MINDIKOGLU AL, PAPPAS SC.New developments in hepatorenal syndrome[J].Clin Gastroenterol Hepatol, 2018, 16 (2) :162-177.
|
|
[22]KARVELLAS CJ, DURAND F, NADIM MK.Acute kidney injury in cirrhosis[J].Crit Care Clin, 2015, 31 (4) :737-750.
|
|
[23]JI GX, GAO FL, FU LK, et al.The significance of serum Cys C andβ2-MG combined with urineα1-MG andβ2-MG on hepatorenal syndrome diagnosis[J].Chin J Gastroenterol Hepatol, 2017, 26 (7) :802-804. (in Chinese) 纪桂贤, 高福来, 付丽坤, 等.血清Cys C、β2-MG联合尿α1-MG、β2-MG在亚临床肝肾综合征诊断中的意义[J].胃肠病学和肝病学杂志, 2017, 26 (7) :802-804.
|
|
[24]CHEN YF, ZHANG YB, LIANG CQ.An analysis of predictive factors for concurrent acute-on-chronic liver failure and hepatorenal syndrome[J].J Clin Hepatol, 2015, 31 (9) :1422-1425. (in Chinese) 陈艳芳, 张永标, 梁彩倩.慢加急性肝衰竭并发肝肾综合征的预测因素分析[J].临床肝胆病杂志, 2015, 31 (9) :1422-1425.
|
|
[25]GTZBERGER M, KAISER C, LANDAUER N, et al.Intrarenal resistance index for the assessment of early renal function impairment in patients with liver cirrhosis[J].Eur J Med Res, 2008, 13 (8) :383-387.
|
|
[26]LOW G, ALEXANDER GJ, LOMAS DJ.Hepatorenal syndrome:Aetiology, diagnosis, and treatment[J].Gastroenterol Res Pract, 2015, 2015:207012.
|
|
[27]MOCARZEL L, LANZIERI P, NASCIMENTO J, et al.Hepatorenal syndrome with cirrhotic cardiomyopathy:Case report and literature review[J].Case Reports Hepatol, 2015, 2015:573513.
|
|
[28]LOW G, ALEXANDER GJ, LOMAS DJ.Renal impairment in cirrhosis unrelated to hepatorenal syndrome[J].Can J Gastroenterol Hepatol, 2015, 29 (5) :253-257.
|
|
[29]HEIDEMANN J, BARTELS C, BERSSENBRUGGE C, et al.Hepatorenal syndrome:Outcome of response to therapy and predictors of survival[J].Gastroenterol Res Pract, 2015, 2015:457613.
|
|
[30]LI H, HAN T, LI Y, et al.The early renal injury and its related factors in patients with chronic HBV infection[J].Chin J Blood Purificat, 2015, 14 (11) :644-648. (in Chinese) 李海, 韩涛, 李岩, 等.慢性乙型肝炎病毒感染患者肾功能早期损伤指标变化及其影响因素[J].中国血液净化, 2015, 14 (11) :644-648.
|
|
[31]SOBHONSLIDSUK A.Current position of vasoconstrictor and albumin infusion for type 1 hepatorenal syndrome[J].World J Gastrointest Pharmacol Ther, 2015, 6 (3) :28-31.
|
|
[32]ALLEGRETTI AS, ORTIZ G, WENGER J, et al.Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis:A prospective cohort study[J].Int J Nephrol, 2015, 2015:108139.
|
|
[33]DAVENPORT A, SHEIKH MF, LAMB E, et al.Acute kidney injury in acute-on-chronic liver failure:Where does hepatorenal syndrome fit?[J].Kidney Int, 2017, 92 (5) :1058-1070.
|
DownLoad: